Table 3.
Changes in the lung function parameters measured at clinic visits in comparison to baseline values
|
BDP/F 400/24 μg/day (N = 206) |
p value |
FP/S 500/100 μg/day (N = 216) |
p value | |
|---|---|---|---|---|
| FEV1, L |
−0.06 (0.03) |
0.089 |
−0.06 (0.03) |
0.109 |
| FEV1% predicted |
−1.72 (0.98) |
0.080 |
−1.91 (0.98) |
0.051 |
| PEF, L/min |
−2.02 (4.57) |
0.658 |
−4.28 (4.55) |
0.347 |
| PEF % predicted |
−0.90 (0.96) |
0.349 |
−1.25 (0.95) |
0.190 |
| Daytime symptoms score |
−0.06 (0.07) |
0.327 |
−0.03 (0.06) |
0.661 |
| Night-time symptom score | 0.20 (0.11) | 0.067 | 0.07 (0.10) | 0.503 |
The values are the adjusted mean (SE) changes from baseline to the end of the study. BDP/F, beclomethasone dipropionate/formoterol; FP/S, fluticasone propionate/salmeterol; FEV1, forced expiratory volume in 1 second; PEF, peak expiratory flow.